These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7405242)
41. [Apropos of emergency management of hemophiliac patients with suspected hemorrhage]. Sultan Y Presse Med; 1999 Mar; 28(11):595-6. PubMed ID: 10214385 [No Abstract] [Full Text] [Related]
42. Acquired factor IX inhibitor in a patient with Christmas disease: case report. Riyat MS; Kasili EG; Omondi BE East Afr Med J; 1984 Feb; 61(2):159-62. PubMed ID: 6468323 [No Abstract] [Full Text] [Related]
43. Plasma support for surgery in a premature infant with factor IX deficiency. Pegelow CH; Borromeo MC; Daghastani D; Bandstra ES Am J Dis Child; 1989 Jun; 143(6):639-40. PubMed ID: 2729202 [No Abstract] [Full Text] [Related]
44. [Hemophilia. New aspects in diagnosis and treatment]. Gormsen J Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776 [No Abstract] [Full Text] [Related]
45. Time dependent factor IX inhibitor. Sarode R; Chauhan AP; Joseph M; Marwaha N; Sharma SK; Dash S Thromb Haemost; 1989 Dec; 62(4):1151. PubMed ID: 2559489 [No Abstract] [Full Text] [Related]
46. Haemophilia. Biggs R Proc R Soc Med; 1969 Sep; 62(9):913-4. PubMed ID: 4241884 [No Abstract] [Full Text] [Related]
47. Substitution treatment of hemophilia a and b. Duckert F Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162 [TBL] [Abstract][Full Text] [Related]
48. [Clinical use of factor IX concentrates]. Nyman D Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901 [TBL] [Abstract][Full Text] [Related]
49. Home treatment of haemophilia and Christmas disease: five years' experience. Rizza CR; Spooner RJ Br J Haematol; 1977 Sep; 37(1):53-66. PubMed ID: 588479 [No Abstract] [Full Text] [Related]
50. A quantitative two-stage assay for factor IX (Christmas factor) using plasma from dogs with Christmas disease. Aronson DL; Dodds WJ; Mustafa AJ Thromb Diath Haemorrh; 1972 Jul; 27(3):529-34. PubMed ID: 4662614 [No Abstract] [Full Text] [Related]
51. [Hemophilia B with inhibitor]. Takahashi I Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):502-5. PubMed ID: 9833555 [No Abstract] [Full Text] [Related]
52. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Santagostino E; Mannucci PM; Gringeri A; Tagariello G; Baudo F; Bauer KA; Rosenberg RD Thromb Haemost; 1994 Jun; 71(6):737-40. PubMed ID: 7974341 [TBL] [Abstract][Full Text] [Related]
54. Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B. Martinowitz U; Lubetsky A Thromb Res; 2013 Mar; 131 Suppl 2():S11-4. PubMed ID: 23537721 [TBL] [Abstract][Full Text] [Related]
55. [Coronary artery bypass with extracorporeal circulation in a patient with hemophilia B]. Bukowski JG; De Brux JL; Ganascia B; Cottineau C; Jacob JP Ann Fr Anesth Reanim; 1996; 15(3):304-6. PubMed ID: 8758585 [TBL] [Abstract][Full Text] [Related]
56. Biochemical and in vivo properties of high purity factor IX concentrates. Berntorp E; Björkman S; Carlsson M; Lethagen S; Nilsson IM Thromb Haemost; 1993 Nov; 70(5):768-73. PubMed ID: 8128433 [TBL] [Abstract][Full Text] [Related]
57. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia]. Schimpf K Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878 [TBL] [Abstract][Full Text] [Related]
59. Transfusion support for haemophiliacs. Allain JP Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835 [No Abstract] [Full Text] [Related]
60. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management. Mahasandana C; Patharathienskul D; Suvatte V Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]